For some people who suffer with severe treatment-resistant depression, there’s good news. Esketamine is a groundbreaking therapy that may provide relief from major depression within hours. Psychiatrist Erica Richards describes who is a candidate for esketamine, which is derived from an anesthetic called ketamine, and how it works. Psychopharmacologist Roland Griffiths focuses on psilocybin research and risk factors of the drug. [ Ссылка ] #AWomansJourney #JohnsHopkins

свернуть